Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Lok

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Clinical Interventions in Aging|September 24, 2014
Tailored lighting intervention improves measures of sleep, depression, and agitation in persons with Alzheimer's disease and related dementia living in long-term care facilitiesMariana G Figueiro, Barbara A Plitnick, Anna Lok, et al.
Clinical Transplantation|November 17, 2010
Clinical outcomes of liver transplantation for HBV-related hepatocellular carcinoma: data from the NIH HBV OLT studySteven-Huy Han, K Rajender Reddy, Emmet B Keeffe, et al.
Nature Communications|April 19, 2012
Convergence and coevolution of hepatitis B virus drug resistanceHong Thai, David S Campo, James Lara, et al.
Journal of Hepatology|January 8, 2004
EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002 Geneva, Switzerland. Consensus statement (long version)Roberto de Franchis, Antoine Hadengue, George Lau, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 31, 2005
Protective antibody levels and dose requirements for IV 5% Nabi Hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced end stage liver diseaseRolland C Dickson, Norah A Terrault, Michael Ishitani, et al.
Journal of Hepatology|April 1, 2026
Long-term outcomes after nucleos(t)ide analogue cessation in chronic hepatitis B - follow-up from the RETRACT-B cohortEdo Dongelmans, Grishma Hirode, Florian van Bӧmmel, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Clinical Interventions in Aging|September 24, 2014
Tailored lighting intervention improves measures of sleep, depression, and agitation in persons with Alzheimer's disease and related dementia living in long-term care facilitiesMariana G Figueiro, Barbara A Plitnick, Anna Lok, et al.
Clinical Transplantation|November 17, 2010
Clinical outcomes of liver transplantation for HBV-related hepatocellular carcinoma: data from the NIH HBV OLT studySteven-Huy Han, K Rajender Reddy, Emmet B Keeffe, et al.
Nature Communications|April 19, 2012
Convergence and coevolution of hepatitis B virus drug resistanceHong Thai, David S Campo, James Lara, et al.
Journal of Hepatology|January 8, 2004
EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002 Geneva, Switzerland. Consensus statement (long version)Roberto de Franchis, Antoine Hadengue, George Lau, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 31, 2005
Protective antibody levels and dose requirements for IV 5% Nabi Hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced end stage liver diseaseRolland C Dickson, Norah A Terrault, Michael Ishitani, et al.
Journal of Hepatology|April 1, 2026
Long-term outcomes after nucleos(t)ide analogue cessation in chronic hepatitis B - follow-up from the RETRACT-B cohortEdo Dongelmans, Grishma Hirode, Florian van Bӧmmel, et al.
Pageof 3